FDA creates new regulatory category for NAC supplement after MAHA push
STAT reports that the FDA has created a new regulatory category for the supplement NAC, which has long been available but operated in a legal gray area. The decision follows advocacy from MAHA and is seen as a shift in how supplements may be regulated in the future.
This matters for pharma and biotech executives because regulatory clarity can affect compliance, market access, and future product strategies. The move may signal further changes in supplement oversight, making it important for regulated firms to track similar developments.